相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway
Dalia A. Shabaan et al.
TISSUE BARRIERS (2023)
Comprehending Cardiac Dysfunction by Oxidative Stress: Untargeted Metabolomics of In Vitro Samples
Alan Goncalves Amaral et al.
FRONTIERS IN CHEMISTRY (2022)
Novel multi-responsive and sugarcane bagasse cellulose-based nanogels for controllable release of doxorubicin hydrochloride
Yuanfeng Pan et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics
Apiwan Arinno et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy
Muhammad Sohail et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
Metabolic Aspects of Anthracycline Cardiotoxicity
Michele Russo et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?
Mojtaba Mollaei et al.
TRANSLATIONAL ONCOLOGY (2021)
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Effimia Christidi et al.
CELL DEATH & DISEASE (2021)
The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study
Maryam Rahmanifard et al.
CARDIOVASCULAR TOXICOLOGY (2021)
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation
Eduard Jirkovsky et al.
CIRCULATION-HEART FAILURE (2021)
Integration of fluxome and transcriptome data in Saccharomyces cerevisiae offers unique features of doxorubicin and imatinib
Hilal Taymaz-Nikerel
MOLECULAR OMICS (2021)
Time-dependent re-organization of biological processes by the analysis of the dynamic transcriptional response of yeast cells to doxorubicin
Muhammed Erkan Karabekmez et al.
MOLECULAR OMICS (2021)
Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat
Ana Flavia M. Botelho et al.
CARDIOVASCULAR TOXICOLOGY (2020)
Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation
Carmine Rocca et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains Unidentified
Daniel H. Breysse et al.
DRUG METABOLISM AND DISPOSITION (2020)
Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor
Jian Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market
Mara Goncalves et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Xuexian Fang et al.
CIRCULATION RESEARCH (2020)
Iron Metabolism in Cancer Progression
Stefania Forciniti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Doxorubicin induces large-scale and differential H2A and H2B redistribution in live cells
Peter Nanasi et al.
PLOS ONE (2020)
Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
Tomonori Tadokoro et al.
JCI INSIGHT (2020)
Functional LAPONITE Nanodisks Enable Targeted Anticancer Chemotherapy in Vivo
Yilun Wu et al.
BIOCONJUGATE CHEMISTRY (2020)
Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles
Mohammad Norouzi et al.
SCIENTIFIC REPORTS (2020)
Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts
T. R. Mancilla et al.
PLOS ONE (2020)
Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency
Christina Schindler et al.
PLOS ONE (2019)
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah et al.
SCIENTIFIC REPORTS (2019)
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity
Carmine Rocca et al.
FASEB JOURNAL (2019)
Triple-threat activity of PEDF in bone tumors: Tumor inhibition, tissue preservation and cardioprotection against doxorubicin
Yongzhong Wei et al.
BONE (2019)
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients
Mariella Spalato Ceruso et al.
CHEMOTHERAPY (2019)
Mechanisms of Anthracycline-Enhanced Reactive Oxygen Metabolism in Tumor Cells
James H. Doroshow
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
Xu Wang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity
K. Melodi McSweeney et al.
CELL DEATH DISCOVERY (2019)
Self-Assembled pH-Responsive Polymeric Micelles for Highly Efficient, Noncytotoxic Delivery of Doxorubicin Chemotherapy To Inhibit Macrophage Activation: In Vitro Investigation
Zhi-Sheng Liao et al.
BIOMACROMOLECULES (2018)
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Steven J. Forrester et al.
CIRCULATION RESEARCH (2018)
11β-Hydroxysteroid Dehydrogenase 1 Human Tissue Distribution, Selective Inhibitor, and Role in Doxorubicin Metabolism
Xin Yang et al.
DRUG METABOLISM AND DISPOSITION (2018)
Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells
Hilal Taymaz-Nikerel et al.
SCIENTIFIC REPORTS (2018)
Enhanced Intestinal Permeation of Doxorubicin Using Chitosan Nanoparticles
Marziyeh Zare et al.
ADVANCED PHARMACEUTICAL BULLETIN (2018)
Monitoring doxorubicin cellular uptake and trafficking using in vitro Raman microspectroscopy: short and long time exposure effects on lung cancer cell lines
Zeineb Farhane et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2017)
Differentiating responses of lung cancer cell lines to Doxorubicin exposure: in vitro Raman micro spectroscopy, oxidative stress and bcl-2 protein expression
Zeineb Farhane et al.
JOURNAL OF BIOPHOTONICS (2017)
Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations
Ruijuan Luo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
A systematic analysis of FDA-approved anticancer drugs
Jingchun Sun et al.
BMC SYSTEMS BIOLOGY (2017)
One-carbon metabolism in cancer
Alice C. Newman et al.
BRITISH JOURNAL OF CANCER (2017)
Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview
Pierantonio Menna et al.
CHEMOTHERAPY (2017)
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a European Pediatric Oncology Off-patents Medicines Consortium trial
Miriam Krischke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin Leakage
Lintao Wang et al.
CANCER RESEARCH (2016)
A Biophysical Systems Approach to Identifying the Pathways of Acute and Chronic Doxorubicin Mitochondrial Cardiotoxicity
Bernardo L. de Oliveira et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
Yanhua Tian et al.
BIOMATERIALS (2014)
Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients
A. L. Wong et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Comparison of pharmacokinetics, tissue distribution and pharmacodynamics of liposomal and free doxorubicin in tumour-bearing mice following intratumoral injection
Shuangxia Ren et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Transcription-generated torsional stress destabilizes nucleosomes
Sheila S. Teves et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
Marzia Lotrionte et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues
Krupa J. Patel et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Doxorubicin Enhances Nucleosome Turnover around Promoters
Fan Yang et al.
CURRENT BIOLOGY (2013)
Doxorubicin treatment inhibits PPARγ and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models
Sankarganesh Arunachalam et al.
FEBS LETTERS (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
Baoxu Pang et al.
NATURE COMMUNICATIONS (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Lack of Effect of Coenzyme Q10 on Doxorubicin Cytotoxicity in Breast Cancer Cell Cultures
Heather Greenlee et al.
INTEGRATIVE CANCER THERAPIES (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Oxidative stress modulates PPARγ in vascular endothelial cells
Carmelo Blanquicett et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein
Tao Wang et al.
NANOMEDICINE (2010)
Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity
Lu Fan et al.
Pharmacogenetics and Genomics (2010)
Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
Suman Lal et al.
CANCER SCIENCE (2008)
Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver
Nina Kassner et al.
DRUG METABOLISM AND DISPOSITION (2008)
Interaction of anthracyclines with iron responsive element mRNAs
Joshua C. Canzoneri et al.
NUCLEIC ACIDS RESEARCH (2008)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Anthracycline cardiotoxicity
Robin L. Jones et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation
MK Doma et al.
NATURE (2006)
Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide
H Mizutani et al.
LIFE SCIENCES (2005)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: Inhibition of the ferritin iron mobilization pathway
JC Kwok et al.
MOLECULAR PHARMACOLOGY (2003)
Unexpected anthracycline-mediated alterations in iron-regulatory protein-RNA-binding activity: The iron and copper complexes of anthracyclines decrease RNA-binding activity
JC Kwok et al.
MOLECULAR PHARMACOLOGY (2002)
Genomic instability in mice lacking histone H2AX
A Celeste et al.
SCIENCE (2002)
Exosome-mediated recognition and degradation of mRNAs lacking a termination codon
A van Hoof et al.
SCIENCE (2002)
An mRNA surveillance mechanism that eliminates transcripts lacking termination codons
PA Frischmeyer et al.
SCIENCE (2002)
Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy
AA Gabizon
CANCER INVESTIGATION (2001)
Doxorubicin metabolism and toxicity in human myocardium: Role of cytoplasmic deglycosidation and carbonyl reduction
S Licata et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)